RGEN
REPLIGEN CORP
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$176.43
+0.58%Forward multiples
Based on analyst estimates
- P/E forward
- 72.59x
- P/E 2026E
- 85.64x
- P/E 2027E
- 66.70x
- P/E 2028E
- 51.05x
- P/S forward
- 12.09x
Trailing multiples
Trailing twelve months
- P/E TTM
- 238.42x
- PEG TTM
- 1.05x
- Price / book
- 5.30x
- Price / sales
- 14.27x
- Price / cash flow
- 83.06x
Enterprise value
- Enterprise value
- $11.1B
- EV / sales
- 14.12x
- EV / EBITDA
- 63.41x
- EV / EBIT
- 169.72x
- Market cap
- $11.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026